Immucell Corp ICCC

$9.60 -0.20 (-2.04%)

Valuation

Market cap
89,006,000
Revenue TTM
$27,640,000
Net income TTM
$-1,040,000
PE ratio
121.88
Forward PE
—
Profit margin
-3.76%
Debt to equity
0.26

Trading

Volume
11,100
Avg volume
20,494
Day's range
$9.60 – $9.80
Shares out
9,082,000
Stochastic %K
11%
Beta
0.56
Analysts
Strong Buy
Price target
$14.00

Price

Company profile

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield Fi...

Show more

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is based in Portland, Maine.

Industry
Biotechnology
Sector
Healthcare
Phone
207 878 2770
Website
https://immucell.com
Address
56 Evergreen Drive, Portland, United States

Latest news

Stocktwits

topstockalerts Oct 13, 11:15 AM
Pre Market Top Gainers PT2 $AIXI $SUGP $YJ $ICCC $ACRS
0 replies
KryptonResearch14 Oct 13, 7:07 AM
$ICCC ImmuCell pre-released Q3 sales after the close Monday: 8.0 million dollars, up 46% YoY. Domestic sales were 6.9 million, up 29.2%, and nine-month sales are 25.6 million, up 27.8%. Growth was broad across the portfolio. Tri-Shield grew 51%, Dual-Force 36%, and the recently launched functional feed line 37%. Management flagged the comp itself though. Q3 last year was depressed because distributors had pulled purchases forward into Q2 2025, so part of that 46% is a soft base. This is also the last early sales release. ImmuCell is dropping preliminary reporting, so the full print on Nov. 13 is the next read.
0 replies
TommyTwenty Oct 12, 8:16 PM
$ICCC https://www.streetinsider.com/dr/news.php?id=27175314&gfv=1
0 replies
theRooster007 Oct 6, 8:12 PM
$ICCC data soon
1 replies
dragonbits Sep 29, 2:37 AM
$ICCC i have owned this for a long time, some shares when it was 3. I bot because of re-tain, when they gave up on approval I thought the stock would crash, but it was trading so strong at the time I kept it. The trading now is a lot different, huge spreads and very little volume. Which makes some sense, those that hold don't want to sell, but there isn't a compelling reason to buy a lot higher, so there is a trickle of shares for sale. I sold ~1/3 when it was above 11. Their sales will continue to ramp up for maybe 3 or more quarters, if re-tain looks positive, not sure how far up the stock will go.
2 replies
theRooster007 Sep 28, 9:23 PM
$ICCC Dec 2025: re-tain study announced April 2026: ceo announces they are now seeking a partner for re-tain June 2026: ceo adds to stock position October 2026: data is due/along with direction they are taking re-tain
1 replies
theRooster007 Sep 19, 2:57 AM
$ICCC Late september-OCT is here. 🥛
1 replies
TommyTwenty Aug 25, 2:55 PM
$ICCC MSU is conducting the investigational studies for retain. We get the results of that test late September/october. MSU is known for this type of research. https://www.canr.msu.edu/news/anti-inflammatories-antimicrobial-resistance
0 replies